Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fever is the elevation of core body temperature above the normal range, regulated by the hypothalamic thermoregulatory center[1]. It is a systemic response to exogenous pyrogens (such as pathogens) and endogenous pyrogens (notably cytokines including IL-1, IL-6, and TNF), which act on the hypothalamus to induce synthesis of prostaglandin E2 (PGE2). PGE2 then binds to EP3 receptors on neurons in the preoptic area (POA) of the hypothalamus, activating neural circuits that increase body temperature through heat generation (brown adipose tissue and shivering) and decreased heat loss (cutaneous vasoconstriction)[1][2][3][4]. Fever supports the body's defense against infection by enhancing immune cell function, but can also represent a metabolic stress.
Not directly applicable, but antipyretic drugs reduce fever primarily by inhibiting cyclooxygenase enzymes (COX-1, COX-2), thus reducing production of prostaglandin E2 (PGE2) in the hypothalamus, and lowering the hypothalamic set-point for body temperature[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fever.